Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 3/20 | 0.54 |
| ▸ | NAAA | Q02083 | 2/20 | 0.49 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | PRKCA | P17252 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13278868 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL2635951 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL15648704 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL247342 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL17203961 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL15649396 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL17204284 | 1.00 | PRCP (0.54) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL16344002 | 0.99 | PRCP (0.52) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL16344007 | 0.99 | PRCP (0.52) | PRCPNAAATLR2DPP7DGKA | |
| SCHEMBL29410656 | 0.99 | PRCP (0.52) | PRCPNAAATLR2DPP7DGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113262175-B | Skin care compositions and methods of use thereof | 尤尼根公司 | 2024-04-16 | — | — | CN | claimed |
| EP-4138770-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | Henkel AG & Co. KGaA (DE) | 2023-03-01 | — | — | EP | claimed |
| CN-115427007-A | Transparent shampoo block and preparation method thereof | 汉高股份有限及两合公司 | 2022-12-02 | — | — | CN | claimed |
| US-11446225-B2 | Skin care compositions and methods of use thereof | UNIGEN, INC. (US) | 2022-09-20 | — | — | US | claimed |
| WO-2021212404-A1 | TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME | HENKEL AG & CO. KGAA (DE) | 2021-10-28 | — | — | WO | claimed |
| CN-113262175-A | Skin care compositions and methods of use thereof | 尤尼根公司 | 2021-08-17 | — | — | CN | claimed |
| CN-105873564-B | Skin care compositions and methods of use thereof | 尤尼根公司 | 2021-01-19 | — | — | CN | claimed |
| US-20200222304-A1 | Skin Care Compositions and Methods of Use Thereof | UNIGEN, INC. (US) | 2020-07-16 | — | — | US | claimed |
| CN-111012682-A | Slimming nano liposome and preparation method and application thereof | 苏州绿叶日用品有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-106794252-A | Pharmaceutical formulations for oral delivery of peptide or protein drugs | 塞浦路迈德有限责任公司 | 2017-05-31 | — | — | CN | claimed |
| US-20160263013-A1 | Skin Care Compositions and Methods of Use Thereof | UNIGEN, INC. (US) | 2016-09-15 | — | — | US | claimed |
| EP-3062767-A1 | SKIN CARE COMPOSITIONS AND METHODS OF USE THEREOF | Unigen, Inc. (US) | 2016-09-07 | — | — | EP | claimed |
| CN-105873564-A | Skin care compositions and methods of use thereof | 尤尼根公司 | 2016-08-17 | — | — | CN | claimed |
| WO-2015066352-A1 | SKIN CARE COMPOSITIONS AND METHODS OF USE THEREOF | UNIGEN, INC. (US) | 2015-05-07 | — | — | WO | claimed |
| WO-2011141685-A2 | SYSTEMIC NASAL COMPOSITIONS COMPRISING COCOYL PROLINE OR AT LEAST ONE OF THE CONSTITUENTS THEREOF | PHYSICA PHARMA SAS (FR) | 2011-11-17 | — | — | WO | claimed |
| EP-4720273-A1 | AMINOACYLASE AND METHODS OF USE THEREOF | BASF SE (DE) | 2026-04-08 | — | — | EP | disclosed |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | NISSHINBO HOLDINGS INC. (JP) | 2026-02-24 | — | — | US | disclosed |
| WO-2003055528-A2 | AMPHIPHILIC COMPOUNDS FOR PHARMACEUTICAL OR COSMETIC USE | PHYSICA S.A.R.L. (FR) | 2003-07-10 | — | — | WO | disclosed |
| EP-0240554-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA, Vithal J. (US) | 1987-10-14 | — | — | EP | disclosed |
| WO-1987001935-A1 | TRANSDERMAL AND SYSTEMIC PREPARATION AND METHOD | RAJADHYAKSHA VITHAL J | 1987-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200222304-A1 | Skin Care Compositions and Methods of Use Thereof | CUTA, LGALS8, RBP1 | PRCP 3348/4885NAAA 3819/4885TLR2 1361/4885 |
| US-20160263013-A1 | Skin Care Compositions and Methods of Use Thereof | CUTA, LGALS8, RBP1 | PRCP 3348/4885NAAA 3819/4885TLR2 1361/4885 |
| US-11446225-B2 | Skin care compositions and methods of use thereof | CUTA, LGALS8, RBP1 | PRCP 3348/4885NAAA 3819/4885TLR2 1361/4885 |
| US-12559611-B2 | Hydrophobic alginic acid particle group and method for producing same | ALG3, ALG1, HACD3 | PRCP 2708/4885NAAA 2615/4885TLR2 332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.